Lars Möllgård

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf et al. · Blood · 2008 · 987 citations

Medicine, Hematology, Oncology +16

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Jeanette Lundin, Eva Kimby, Magnus Björkholm et al. · Blood · 2002 · 499 citations · Full text

Medicine, Hematology, Oncology +16

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry

Sylvain Lehmann, Lotta Höglund Carlsson, P Antunović et al. · Leukemia · 2011 · 354 citations

Medicine, Hematology, Oncology +12

Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: <scp>A</scp> report from the <scp>S</scp>wedish <scp>A</scp>cute <scp>L</scp>eukemia <scp>R</scp>egistry

Erik Hulegårdh, Christer Nilsson, Vladimir Lazarević et al. · American Journal of Hematology · 2014 · 278 citations · Full text

Medicine, Hematology, Oncology +13

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Jean‐Luc Harousseau, Giovanni Martinelli, W Wiktor-Jędrzejczak et al. · Blood · 2009 · 145 citations · Full text

Medicine, Oncology, Pharmacology +11